Raven Jaeger
General Counsel bei CALCIMEDICA, INC.
Profil
Raven D.
Jaeger is currently the Chief Regulatory Officer at CalciMedica, Inc. Prior to this, she held the position of Director-Regulatory Affairs at Leadiant Biosciences, Inc. from 2011 to 2018.
In 2022, she served as the Chief Regulatory Officer at Diffusion Pharmaceuticals, Inc. Ms. Jaeger also worked as the Senior Vice President-Regulatory Affairs at BridgeBio Pharma, Inc. Ms. Jaeger completed her undergraduate degree at The Johns Hopkins University and her graduate degree at the University of Maryland.
Aktive Positionen von Raven Jaeger
| Unternehmen | Position | Beginn |
|---|---|---|
| CALCIMEDICA, INC. | General Counsel | 23.05.2023 |
Ehemalige bekannte Positionen von Raven Jaeger
| Unternehmen | Position | Ende |
|---|---|---|
| DIFFUSION PHARMA | General Counsel | 01.03.2023 |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.04.2018 |
| BRIDGEBIO PHARMA, INC. | General Counsel | - |
Ausbildung von Raven Jaeger
| The Johns Hopkins University | Undergraduate Degree |
| University of Maryland | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRIDGEBIO PHARMA, INC. | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
